Search Results

There are 2883 results for: content related to: The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer

  1. Comparative pharmacokinetics and pharmacodynamics of epoetin alfa and epoetin beta

    Clinical Pharmacology & Therapeutics

    Volume 50, Issue 6, December 1991, Pages: 702–712, Charles E Halstenson, Mark Macres, Stephen A Katz, James R Schnieders, Masakazu Watanabe, Joseph T Sobota and Paul A Abraham

    Version of Record online : 3 DEC 1991, DOI: 10.1038/clpt.1991.210

  2. Recombinant human erythropoietin in pediatric oncology: A review

    Medical and Pediatric Oncology

    Volume 39, Issue 4, October 2002, Pages: 463–468, James Feusner and Caroline Hastings

    Version of Record online : 29 AUG 2002, DOI: 10.1002/mpo.10187

  3. Assessment of hemoglobin responsiveness to epoetin alfa in patients on hemodialysis using a population pharmacokinetic pharmacodynamic model

    The Journal of Clinical Pharmacology

    Volume 55, Issue 10, October 2015, Pages: 1157–1166, Liviawati Wu, Diane R. Mould, Juan Jose Perez Ruixo and Sameer Doshi

    Version of Record online : 21 JUL 2015, DOI: 10.1002/jcph.527

  4. Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy

    Hematological Oncology

    Volume 21, Issue 4, December 2003, Pages: 169–180, Timothy J. Littlewood, Johan Nortier, Bernardo Rapoport, Marek Pawlicki, Gilbert De Wasch, Els Vercammen, Wolfgang Schuette, Jacques Wils and Mathias Freund

    Version of Record online : 15 JAN 2004, DOI: 10.1002/hon.722

  5. Review of Patients' Responses to Epoetin Alfa Therapy

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 10, Issue 2P2, March-April 1990, Pages: 15S–21S, Sanford B. Krantz

    Version of Record online : 24 JAN 2012, DOI: 10.1002/j.1875-9114.1990.tb02568.x

  6. Epoetin alfa for the Treatment of Combination Therapy–Induced Hemolytic Anemia in Patients Infected with Hepatitis C Virus

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 25, Issue 6, June 2005, Pages: 862–875, Dr. Anastasia M. Rivkin and Sweta Chawla

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.2005.25.6.862

  7. You have free access to this content
    Anemia in Patients With Cancer or Undergoing Cancer Therapy: Impact and Current Treatment Practice

    Transfusion Alternatives in Transfusion Medicine

    Volume 6, Issue 3, February 2005, Pages: 14–25, David H. Henry

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1778-428X.2005.tb00120.x

  8. Is epoetin alfa a treatment option for chemotherapy-related anemia in children?

    Medical and Pediatric Oncology

    Volume 39, Issue 4, October 2002, Pages: 455–458, Münevver Büyükpamukçu, Ali Varan, Tezer Kutluk and Canan Akyüz

    Version of Record online : 29 AUG 2002, DOI: 10.1002/mpo.10185

  9. Managing Anemia in the Critically Ill Patient

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 2, February 2004, Pages: 229–247, Dr. Maria I. Rudis, Dr. Judith Jacobi, Dr. Erkan Hassan and Mrs. Joseph F. Dasta

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.24.2.229.33135

  10. Comparison between Intravenous and Subcutaneous Recombinant Human Erythropoietin (Epoetin Alfa) Administration in Presurgical Autologous Blood Donation in Anemic Rheumatoid Arthritis Patients Undergoing Major Orthopedic Surgery

    Vox Sanguinis

    Volume 72, Issue 2, February 1997, Pages: 93–100, F. Mercuriali, G. Inghilleri, E. Biffi, M. T. Colotti, A. Vinci, L. Sinigaglia and G. Gualtieri

    Version of Record online : 9 MAY 2003, DOI: 10.1046/j.1423-0410.1997.7220093.x

  11. Evaluation of the US Oncology Network's Recommended Guidelines for Therapeutic Substitution with Darbepoetin alfa 200 μg Every 2 Weeks in Both Naïve Patients and Patients Switched from Epoetin alfa

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 3, March 2004, Pages: 313–323, William A. Thames, Sandra L. Smith, Andrew C. Scheifele, Bin Yao, Suzana A. Giffin and Julie L. Alley

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.24.4.313.33180

  12. Early epoetin alfa treatment in children with solid tumors

    Medical and Pediatric Oncology

    Volume 39, Issue 4, October 2002, Pages: 459–462, Andreas Zoubek and Martina Kronberger

    Version of Record online : 29 AUG 2002, DOI: 10.1002/mpo.10186

  13. Population Pharmacokinetic Modeling of Epoetin Delta in Pediatric Patients With Chronic Kidney Disease

    The Journal of Clinical Pharmacology

    Volume 48, Issue 7, July 2008, Pages: 837–848, Dr William Knebel, Dr Mary Palmen, Dr James A. Dowell and Dr Marc Gastonguay

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008318218

  14. You have free access to this content
    Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis

    Intervention Review

    The Cochrane Library

    Suetonia C Palmer, Valeria Saglimbene, Dimitris Mavridis, Georgia Salanti, Jonathan C Craig, Marcello Tonelli, Natasha Wiebe and Giovanni FM Strippoli

    Published Online : 8 DEC 2014, DOI: 10.1002/14651858.CD010590.pub2

  15. Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects*

    Clinical Pharmacology & Therapeutics

    Volume 64, Issue 4, October 1998, Pages: 412–423, Wing K. Cheung, Betty L. Goon, Mary C. Guilfoyle and Mary C. Wacholtz

    Version of Record online : 16 OCT 1998, DOI: 10.1016/S0009-9236(98)90072-8

  16. Biosimilar Epoetins: An Analysis Based on Recently Implemented European Medicines Evaluation Agency Guidelines on Comparability of Biopharmaceutical Proteins

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 25, Issue 7, July 2005, Pages: 954–962, Dr. Christian Combe, Dr. Roger L. Tredree and Dr. Huub Schellekens

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.2005.25.7.954

  17. Population Pharmacokinetic and Pharmacodynamic Model-Based Comparability Assessment of a Recombinant Human Epoetin Alfa and the Biosimilar HX575

    The Journal of Clinical Pharmacology

    Volume 52, Issue 11, November 2012, Pages: 1624–1644, Mr Xiaoyu Yan, Dr Philip J. Lowe, Dr Martin Fink, Dr Alexander Berghout, Dr Sigrid Balser and Dr Wojciech Krzyzanski

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011421911

  18. Anaphylactic Shock at the End of Hemodialysis

    Seminars in Dialysis

    Volume 28, Issue 6, November–December 2015, Pages: 661–664, Nivin Aziz, Carla Luna, Farheen Mirza and Mary Tobin

    Version of Record online : 4 JUL 2015, DOI: 10.1111/sdi.12402

  19. Perspectives on the Improvement of Quality of Life with Epoetin Alfa Therapy

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 10, Issue 2P2, March-April 1990, Pages: 22S–26S, A. Peter Lundin, Barbara G. Delano and Rosemary Quinn-Cefaro

    Version of Record online : 24 JAN 2012, DOI: 10.1002/j.1875-9114.1990.tb02569.x

  20. Dialysis patients treated with Epoetin alfa show improved anemia symptoms: A new analysis of the Canadian Erythropoietin Study Group trial

    Hemodialysis International

    Volume 14, Issue 2, April 2010, Pages: 168–173, Paul A. KEOWN, David N. CHURCHILL, Melanie POULIN-COSTELLO, Lei LEI, Sandeep GANTOTTI, Irene AGODOA, Matthew GITLIN, Shravanthi R. GANDRA and Tracy J. MAYNE

    Version of Record online : 24 MAR 2010, DOI: 10.1111/j.1542-4758.2009.00422.x